BCAL Diagnostics Limited BDX
ASX · Australia · Health Services
AUD 0.0920+0.00 (+2.22%)
Market open· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Zacks cited Becton Dickinson’s growth initiatives and cost savings, while warning that reimbursement uncertainty and competition remain challenges.
RMD has trailed healthcare stocks over 12 months, but improving earnings, cash flow and buybacks complicate the bearish case.